PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious ...

License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy. $117.3 Million in Cash and Cash Equivalents at M ...

VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its ...

Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Headshot of Dieter Weinand Dieter Weinand, Chairman of the Board of Sibylla Biotech Milan, Italy, May 8, 2025 – Sibylla Biotech today announced the appointment of Dieter Weinand as Chairman of its ...

It will use the funds for cardiomyopathy therapy development. Singapore-headquartered IND-stage biotechnology company ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction democratization.

In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as a novel ...

At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.

Austrian researchers have unlocked a groundbreaking property of graphene, making it significantly more stretchable ...